<DOC>
	<DOCNO>NCT00936260</DOCNO>
	<brief_summary>The purpose study determine duration treatment alendronate postmenopausal woman osteoporosis .</brief_summary>
	<brief_title>Drug Holidays Treatment With Alendronate Postmenopausal Women With Osteoporosis</brief_title>
	<detailed_description>The duration treatment alendronate well establish . The investigator recruit 228 woman postmenopausal osteoporosis . They receive alendronate first 3 year monitor later randomize whether different regimen intermittent treatment carry 3 year .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>postmenopausal osteoporosis densitometric criterion World Health Organization secondary osteoporosis alteration analytic parameter ( total protein , calcium , phosphorus , vitamin D , parathyroid hormone , thyroid hormone , transaminase , creatinine )</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 1998</verification_date>
	<keyword>osteoporosis</keyword>
	<keyword>postmenopausal</keyword>
	<keyword>alendronate</keyword>
</DOC>